Marina S.D. Milan

520 total citations
7 papers, 126 citations indexed

About

Marina S.D. Milan is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Marina S.D. Milan has authored 7 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Marina S.D. Milan's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (3 papers). Marina S.D. Milan is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Research Studies (3 papers). Marina S.D. Milan collaborates with scholars based in United States, United Kingdom and Japan. Marina S.D. Milan's co-authors include Geoffrey R. Oxnard, Cloud P. Paweletz, Julianna Supplee, Lynette M. Sholl, Kristy Potts, Lee P. Lim, Michael L. Cheng, Pasi A. Jänne, Mark M. Awad and Kenneth L. Kehl and has published in prestigious journals such as Cancer Research, Journal of Thoracic Oncology and Lung Cancer.

In The Last Decade

Marina S.D. Milan

7 papers receiving 125 citations

Peers

Countries citing papers authored by Marina S.D. Milan

Since Specialization

Citations

This map shows the geographic impact of Marina S.D. Milan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina S.D. Milan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina S.D. Milan more than expected).

Fields of papers citing papers by Marina S.D. Milan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina S.D. Milan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina S.D. Milan. The network helps show where Marina S.D. Milan may publish in the future.

Co-authorship network of co-authors of Marina S.D. Milan

This figure shows the co-authorship network connecting the top 25 collaborators of Marina S.D. Milan. A scholar is included among the top collaborators of Marina S.D. Milan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina S.D. Milan. Marina S.D. Milan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLC 2021 ·JCO Precision Oncology ·Michael L. Cheng, Marina S.D. Milan, (unknown), Arrien A. Bertram, (unknown), Biagio Ricciuti, Kenneth L. Kehl, Mark M. Awad, Lynette M. Sholl, Cloud P. Paweletz, Pasi A. Jänne	15
2	Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC 2021 ·JCO Precision Oncology ·Michael L. Cheng, Christie J. Lau, Marina S.D. Milan, Julianna Supplee, Jonathan W. Riess, Penelope A. Bradbury, Pasi A. Jänne, Geoffrey R. Oxnard, Cloud P. Paweletz	20
3	P34.04 Circulating Tumor DNA (ctDNA) as a Marker of Progressive Disease in Patients with Advanced Lung Cancer 2021 ·Journal of Thoracic Oncology ·Bryan C. Ulrich, Cloud P. Paweletz, Marina S.D. Milan, Geoffrey R. Oxnard, Pasi A. Jänne, Julia Rotow	1
4	High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content 2021 ·JCO Precision Oncology ·Catherine B. Meador, Marina S.D. Milan, (unknown), Mark M. Awad, Michael S. Rabin, Cloud P. Paweletz, Ryan J. Hartmaier, Gianluca Laus, Geoffrey R. Oxnard	8
5	Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis 2020 ·JCO Precision Oncology ·Yi Lee, (unknown), Marina S.D. Milan, (unknown), (unknown), Mark M. Awad, David A. Barbie, Michael L. Cheng, Kenneth L. Kehl, Judith Marcoux, Michael S. Rabin, Julia Rotow, Jacob Sands, Pasi A. Jänne, Geoffrey R. Oxnard	21
6	Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA 2019 ·Lung Cancer ·Julianna Supplee, Marina S.D. Milan, Lee P. Lim, Kristy Potts, Lynette M. Sholl, Geoffrey R. Oxnard, Cloud P. Paweletz	60
7	Abstract 1374: Building an effective concordance study: Plasma Next Generation Sequencing (NGS) for oncogenic fusion detection in non-small cell lung carcinoma (NSCLC) 2019 ·Cancer Research ·Julianna Supplee, Marina S.D. Milan, Kristy Potts, Lynette M. Sholl, Tristan Shaffer, Lee P. Lim, Pasi A. Jänne, Geoffrey R. Oxnard, Cloud P. Paweletz	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact